BV Management Fund Privium Net Worth & Insider Trades
BV Management Fund Privium Applied Genetic Technologies Corp
What is BV Management Fund Privium's Net Worth?
The current estimated net worth of Applied Genetic Technologies Corp's BV Management Fund Privium is estimated to be about $930.99K . BV Management Fund Privium owns about 1,805,761 units of Applied Genetic Technologies Corp common stock. In the last month at Applied Genetic Technologies Corp, BV Management Fund Privium has sold an estimated value of $425.29K worth.
What is BV Management Fund Privium's Past Insider Trading?
BV Management Fund Privium's largest purchase order was 2,544 units , worth over $7.1K on November 26, 2019. BV Management Fund Privium's largest sale order was 81,162 units , worth over $425.29K on December 30, 2019. In total, BV Management Fund Privium has made about 2 transactions over a month of their time at Applied Genetic Technologies Corp. BV Management Fund Privium usually trades in December and November, with the busiest year in 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Hendrik Johan Patrick Krol, Aescap Stichting, BV Management Fund Privium, BV Visions Inspirational
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is BV Management Fund Privium's' Mailing Address?
- Mailing address is Gustav Mahlerplein 3 Amsterdam P7 1082 MS Netherlands
What are Applied Genetic Technologies Corp's Past Insider Trades?
Applied Genetic Technologies Corp's most recent insider trade came on July 1, 2022 by Stephen Potter who sold 8,070 units worth $6.25K . In the last 8 years, insiders at Applied Genetic Technologies Corp have sold an estimated value of $13.01M and bought an estimated value of $9.13M worth of shares. Insider trading is most common in December, with the busiest year in 2018. The most active traders at the company are Matthew Feinsod, Exec. VP, Susan Washer, President and CEO, and Stephen Potter, Chief Business Officer .
APPLIED GENETIC TECHNOLOGIES CORP Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |